MOR - Morphosys AG - ADR
Close
18.96
0.450 2.373%
Share volume: 19,165
Last Updated: Fri 02 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$18.51
0.45
2.43%
Summary score
15%
Profitability
6%
Dept financing
7%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-2.86%
Return on assets
-2.91%
Return on sales
-180.13%
Return on invested capital
-14.32%
Total debt ratio
17.97%
Debt ratio change over timeo
-1.7%
Current Ratio
7.83%
Quick Ratio
7.82%
Cash Position Ratio
1.8%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0.82%
Return on assets
-0.85%
Return on sales
-216.12%
Return on invested capital
5.89%
Total debt ratio
35.61%
Debt ratio change over timeo
-2.22%
Current Ratio
7.75%
Quick Ratio
7.73%
Cash Position Ratio
2.35%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.93%
Return on assets
-3.33%
Return on sales
-262.38%
Return on invested capital
-16.04%
Total debt ratio
53.9%
Debt ratio change over time
-0.53%
Current Ratio
5.41%
Quick Ratio
5.32%
Cash Position Ratio
0.19%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-86.1%
Return on assets
-85.96%
Return on sales
422.57%
Return on invested capital
-21.08%
Total debt ratio
-169.97%
Debt ratio change over time
-1.7%
Current Ratio
-36.39%
Quick Ratio
-36.36%
Cash Position Ratio
-9.34%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MOR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -2.86% | -3.05% | 11.55% | 6.27% |
| Return on assets | -2.91% | 3.6% | 3.57% | 5.27% |
| Return on sales | -180.13% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -14.32% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 17.97% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.7% | 6.09% | 6.03% | 1.53% |
| Dept financing | 4% | 50% | 43% | 14% |
| Current Ratio | 7.75% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 7.73% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.35% | 1.48% | 0.76% | 1.49% |
| Liquididy | 75% | 19% | 30% | 39% |
| Short-term ratios | MOR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 0.82% | -25.62% | 17.94% | 7.14% |
| Return on assets | -0.85% | 3.26% | 3.67% | 4.71% |
| Return on sales | -216.12% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 5.89% | 8.14% | 7.17% | 18.16% |
| Profitability | 9% | 49% | 79% | 82% |
| Total debt ratio | 35.61% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -2.22% | -23.44% | 9.66% | 0.6% |
| Dept financing | 8% | 25% | 45% | 8% |
| Current Ratio | 7.75% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 7.73% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.35% | 1.48% | 0.76% | 1.49% |
| Liquididy | 75% | 29% | 20% | 36% |